The synergistic effect of hypoglycemia and L-asparaginase upon transplantable hepatomas of varying growth rates.
D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology; D002460:Cell Line; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D004926:Escherichia coli / Q000201:enzymology; D005947:Glucose / Q000494:pharmacology; D006406:Hematoma / Q000378:metabolism*; D006498:Hepatectomy; D007003:Hypoglycemia / Q000503:physiopathology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D008113:Liver Neoplasms / Q000378:metabolism* / Q000503:physiopathology; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000378:metabolism; D051381:Rats; D011912:Rats, Inbred ACI; D011919:Rats, Inbred Strains; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D004273:DNA, Neoplasm; D014316:Tritium; D001215:Asparaginase; D005947:Glucose; D013936:Thymidine